Thus, the role of CD46 as a metabolic driver points to its involvement in malignant transformation and/or cellular proliferation, especially because cancer cells are known to be highly glycolytic and to anaerobically metabolize glucose (85, 86). The gene discussed is CD46; the disease is cancer.